{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T01:18:40Z","timestamp":1778030320929,"version":"3.51.4"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.lfs.2020.118818","type":"journal-article","created":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T13:02:53Z","timestamp":1606827773000},"page":"118818","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Autophagy blockade mechanistically links proton pump inhibitors to worsened diabetic nephropathy and aborts the renoprotection of metformin\/enalapril"],"prefix":"10.1016","volume":"265","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5057-2491","authenticated-orcid":false,"given":"Dalia Kamal","family":"Mostafa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Mostafa","family":"Khedr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mervat Kamel","family":"Barakat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amany Abdelbary","family":"Abdellatif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal Mohamed","family":"Elsharkawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2020.118818_bb0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5009\/gnl15502","article-title":"25 years of proton pump inhibitors: a comprehensive review","volume":"11","author":"Strand","year":"2017","journal-title":"Gut Liver"},{"key":"10.1016\/j.lfs.2020.118818_bb0010","article-title":"Potential harms of proton pump inhibitor therapy: rare adverse effects of commonly used drugs","author":"Benmassaoud","year":"2015","journal-title":"CMAJ"},{"key":"10.1016\/j.lfs.2020.118818_bb0015","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/pds.4043","article-title":"Proton pump inhibitor prescribing patterns in the UK: a primary care database study","volume":"25","author":"Othman","year":"2016","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.lfs.2020.118818_bb0020","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/phar.2235","article-title":"Proton pump inhibitors and risk of acute and chronic kidney disease: a retrospective cohort study","volume":"2019","author":"Hart","year":"2019","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.lfs.2020.118818_bb0025","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s40620-016-0309-2","article-title":"PPIs and kidney disease: from AIN to CKD","volume":"29","author":"Moledina","year":"2016","journal-title":"J. Nephrol."},{"key":"10.1016\/j.lfs.2020.118818_bb0030","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12882-016-0325-4","article-title":"Proton pump inhibitors are associated with increased risk of development of chronic kidney disease","volume":"17","author":"Arora","year":"2016","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.lfs.2020.118818_bb0035","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jamainternmed.2015.7193","article-title":"Proton pump inhibitor use and the risk of chronic kidney disease","volume":"176","author":"Lazarus","year":"2016","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.lfs.2020.118818_bb0040","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.lfs.2020.118818_bb0045","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1210\/jc.2017-00354","article-title":"Proton pump inhibitors, nephropathy, and cardiovascular disease in type 2 diabetes: the Fremantle diabetes study","volume":"102","author":"Davis","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2020.118818_bb0050","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.diabres.2018.11.019","article-title":"Proton pump inhibitors use and risk of chronic kidney disease in diabetic patients","volume":"147","author":"Yang","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.lfs.2020.118818_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141779","article-title":"Multimorbidities and overprescription of proton pump inhibitors in older patients","volume":"10","author":"Delcher","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2020.118818_bb0060","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41419-018-0642-6","article-title":"The proton pump inhibitor pantoprazole disrupts protein degradation systems and sensitizes cancer cells to death under various stresses","volume":"9","author":"Cao","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2020.118818_bb0065","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13046-014-0073-x","article-title":"Proton pump inhibitors (PPIs) impact on tumour cell survival, metastatic potential and chemotherapy resistance, and affect expression of resistance-relevant miRNAs in esophageal cancer","volume":"33","author":"Lindner","year":"2014","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2020.118818_bb0070","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12860-019-0227-y","article-title":"Proton pump inhibitors can reverse the YAP mediated paclitaxel resistance in epithelial ovarian cancer","volume":"20","author":"He","year":"2019","journal-title":"BMC Mol. Cell Biol."},{"key":"10.1016\/j.lfs.2020.118818_bb0075","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3389\/fphar.2016.00452","article-title":"Proton pump inhibitors display antitumor effects in Barrett\u2019s adenocarcinoma cells","volume":"7","author":"Chueca","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2020.118818_bb0080","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1530\/JOE-14-0437","article-title":"Autophagy in diabetic nephropathy","volume":"224","author":"Ding","year":"2015","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.lfs.2020.118818_bb0085","first-page":"3182","article-title":"The activity and role of autophagy in the pathogenesis of diabetic nephropathy","volume":"22","author":"Liu","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.lfs.2020.118818_bb0090","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4093\/dmj.2015.39.6.451","article-title":"Autophagy: a novel therapeutic target for diabetic nephropathy","volume":"39","author":"Kume","year":"2015","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.lfs.2020.118818_bb0095","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev-biophys-060414-034248","article-title":"Mechanisms of autophagy","volume":"44","author":"Noda","year":"2015","journal-title":"Annu. Rev. Biophys."},{"key":"10.1016\/j.lfs.2020.118818_bb0100","article-title":"Autophagy attenuates diabetic glomerular damage through protection of hyperglycemia induced podocyte injury","volume":"8","author":"Fang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2020.118818_bb0105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.krcp.2016.02.004","article-title":"Adenosine monophosphate-activated protein kinase in diabetic nephropathy","volume":"35","author":"Kim","year":"2016","journal-title":"Kidney Res. Clin. Pract."},{"key":"10.1016\/j.lfs.2020.118818_bb0110","doi-asserted-by":"crossref","first-page":"F881","DOI":"10.1152\/ajprenal.00373.2007","article-title":"Control of glycogen synthase through ADIPOR1-AMPK pathway in renal distal tubules of normal and diabetic rats","volume":"294","author":"Cammisotto","year":"2008","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.lfs.2020.118818_bb0115","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1073\/pnas.0712145105","article-title":"A role for the NAD dependent deacetylase Sirt1 in the regulation of autophagy","volume":"105","author":"Lee","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2020.118818_bb0120","first-page":"2495","article-title":"Role of mTOR signaling in the regulation of high glucose-induced podocyte injury","volume":"17","author":"Li","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.lfs.2020.118818_bb0125","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-981-15-0602-4_3","article-title":"Regulation of autophagy by mTOR signaling pathway","volume":"1206","author":"Wang","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.lfs.2020.118818_bb0130","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1080\/15548627.2019.1580512","article-title":"Podocytes and autophagy: a potential therapeutic target in lupus nephritis","volume":"15","author":"Zhou","year":"2019","journal-title":"Autophagy."},{"key":"10.1016\/j.lfs.2020.118818_bb0135","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1053\/j.ajkd.2012.07.005","article-title":"KDOQI clinical practice guideline for diabetes and CKD: 2012 update","volume":"60","author":"National Kidney Foundation","year":"2012","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.lfs.2020.118818_bb0140","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejphar.2016.10.031","article-title":"Pleotropic protective effects of vitamin D against high fat diet induced metabolic syndrome in rats: one for all","volume":"792","author":"Mostafa","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2020.118818_bb0145","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1440-1797.2007.00796.x","article-title":"Rodent models of streptozotocin-induced diabetic nephropathy","volume":"12","author":"Tesch","year":"2007","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.lfs.2020.118818_bb0150","doi-asserted-by":"crossref","first-page":"e66617","DOI":"10.1371\/journal.pone.0066617","article-title":"The proton pump inhibitor lansoprazole improves the skeletal phenotype in dystrophin deficient mdx mice","volume":"8","author":"Sali","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2020.118818_bb0155","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.expneurol.2018.09.008","article-title":"Metformin attenuates diabetes-induced tau hyperphosphorylation in vitro and in vivo by enhancing autophagic clearance","volume":"311","author":"Chen","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.lfs.2020.118818_bb0160","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1291\/hypres.28.243","article-title":"Different effects of imidapril and enalapril on aminopeptidase P activity in the mouse trachea","volume":"28","author":"Sakamoto","year":"2005","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.lfs.2020.118818_bb0165","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.2337\/diacare.46.10.1612","article-title":"Role of angiotensin \u0399\u0399 and bradykinin in experimental diabetic nephropathy. Functional and structural studies","volume":"46","author":"Allen","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2020.118818_bb0170","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2020.118818_bb0175","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1590\/S0102-865020150040000007","article-title":"Renal biomarkers of male and female wistar rats (Rattus norvegicus) undergoing renal ischemia and reperfusion","volume":"30","author":"Bazzano","year":"2015","journal-title":"Acta Cir. Bras."},{"key":"10.1016\/j.lfs.2020.118818_bb0180","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides for animal tissues by thiobarbituric acidreaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.lfs.2020.118818_bb0185","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1681\/ASN.2010010010","article-title":"Pathologic classification of diabetic nephropathy","volume":"21","author":"Tervaert","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.lfs.2020.118818_bb0190","first-page":"2481","article-title":"Reliable LC3 and p62 autophagy marker detection in formalin fixed paraffin embedded human tissue by immunohistochemistry","volume":"59","author":"Schl\u00e4fli","year":"2015","journal-title":"E.J.H."},{"key":"10.1016\/j.lfs.2020.118818_bb0195","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1111\/cas.12756","article-title":"Influence of the proton pump inhibitor lansoprazole on distribution and activity of doxorubicin in solid tumors","volume":"106","author":"Yu","year":"2015","journal-title":"Cancer Sci."},{"key":"10.1016\/j.lfs.2020.118818_bb0200","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.2174\/138161212799504821","article-title":"Intracellular proton pumps as targets in chemotherapy: V-ATPases and cancer","volume":"18","author":"Hernandez","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.lfs.2020.118818_bb0205","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1080\/15548627.2015.1049799","article-title":"Endothelial cell and podocyte autophagy synergistically protect from diabetes-induced glomerulosclerosis","volume":"11","author":"Lenoir","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.lfs.2020.118818_bb0210","doi-asserted-by":"crossref","first-page":"3560238","DOI":"10.1155\/2017\/3560238","article-title":"Podocyte autophagy: a potential therapeutic target to prevent the progression of diabetic nephropathy","volume":"2017","author":"Liu","year":"2017","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.lfs.2020.118818_bb0215","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1080\/15548627.2015.1115173","article-title":"Emerging role of podocyte autophagy in the progression of diabetic nephropathy","volume":"11","author":"Yasuda-Yamahara","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.lfs.2020.118818_bb0220","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4161\/auto.19496","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy","volume":"8","author":"Klionsky","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.lfs.2020.118818_bb0225","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4161\/auto.5338","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes","volume":"4","author":"Klionsky","year":"2008","journal-title":"Autophagy"},{"key":"10.1016\/j.lfs.2020.118818_bb0230","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1083\/jcb.200507002","article-title":"p62\/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death","volume":"171","author":"Bjorkoy","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.lfs.2020.118818_bb0235","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cell.2010.01.028","article-title":"Methods in mammalian autophagy research","volume":"140","author":"Mizushima","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2020.118818_bb0240","article-title":"Differential modulation of autophagy contributes to the protective effects of resveratrol and co-enzyme Q10 in photoaged mice","author":"Mostafa","year":"2020","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.lfs.2020.118818_bb0245","doi-asserted-by":"crossref","first-page":"783","DOI":"10.4161\/auto.6477","article-title":"Autophagy protects renal tubular cells against cyclosporine toxicity","volume":"4","author":"Pallet","year":"2008","journal-title":"Autophagy"},{"key":"10.1016\/j.lfs.2020.118818_bb0250","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1042\/EBC20170027","article-title":"mTORC1 as the main gateway to autophagy","volume":"61","author":"Rabanal-Ruiz","year":"2017","journal-title":"Essays Biochem."},{"key":"10.1016\/j.lfs.2020.118818_bb0255","doi-asserted-by":"crossref","first-page":"20499","DOI":"10.1074\/jbc.M115.666354","article-title":"Autophagy-lysosome pathway in renal tubular epithelial cells is disrupted by advanced glycation end products in diabetic nephropathy","volume":"290","author":"Liu","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2020.118818_bb0260","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2169\/internalmedicine.43.9","article-title":"Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure","volume":"43","author":"Nangaku","year":"2004","journal-title":"Intern. Med."},{"key":"10.1016\/j.lfs.2020.118818_bb0265","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.3389\/fphys.2018.01939","article-title":"High dose vitamin E attenuates diabetic nephropathy via alleviation of autophagic stress","volume":"9","author":"Zhao","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.lfs.2020.118818_bb0270","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/labinvest.2014.2","article-title":"Thioredoxin-interacting protein mediates dysfunction of tubular autophagy in diabetic kidneys through inhibiting autophagic flux","volume":"94","author":"Huang","year":"2014","journal-title":"Lab. Investig."},{"key":"10.1016\/j.lfs.2020.118818_bb0275","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1124\/jpet.111.186866","article-title":"Dipeptidyl peptidase IV inhibitor attenuates kidney injury in streptozotocin induced diabetic rats","volume":"340","author":"Liu","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.lfs.2020.118818_bb0280","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4093\/dmj.2015.39.6.451","article-title":"Autophagy: a novel therapeutic target for diabetic nephropathy","volume":"39","author":"Shinji","year":"2015","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.lfs.2020.118818_bb0285","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.kint.2016.12.021","article-title":"Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury","volume":"91","author":"Xie","year":"2017","journal-title":"Kidney Int."},{"key":"10.1016\/j.lfs.2020.118818_bb0290","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.freeradbiomed.2015.06.014","article-title":"p62 links autophagy and Nrf2 signaling","volume":"88","author":"Jiang","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2020.118818_bb0295","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1128\/MCB.00248-10","article-title":"A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62","volume":"30","author":"Lau","year":"2010","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.lfs.2020.118818_bb0300","doi-asserted-by":"crossref","DOI":"10.4172\/2155-6156.1000547","article-title":"Reactive oxygen species and nuclear factor erythroid 2-related factor 2 activation in diabetic nephropathy: a hidden target","volume":"6","author":"Abdo","year":"2015","journal-title":"J. Diabetes Metab."},{"key":"10.1016\/j.lfs.2020.118818_bb0305","article-title":"Metformin reduces saturated fatty acid-induced lipid accumulation and inflammatory response by restoration of autophagic flux in endothelial cells","volume":"10","author":"Kim","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2020.118818_bb0310","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41598-018-37247-6","article-title":"Metformin prevents cell tumorigenesis through autophagyrelated cell death","volume":"9","author":"Santi","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2020.118818_bb0315","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/ki.2010.11","article-title":"Metformin prevents experimental gentamicin-induced nephropathy by a mitochondria-dependent pathway","volume":"77","author":"Morales","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.lfs.2020.118818_bb0320","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.2337\/db10-0351","article-title":"Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice","volume":"60","author":"Xie","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2020.118818_bb0325","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/nyas.13131","article-title":"Transcription factor EB: from master coordinator of lysosomal pathways to candidate therapeutic target in degenerative storage diseases","volume":"1371","author":"Sardiello","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.lfs.2020.118818_bb0330","doi-asserted-by":"crossref","first-page":"e31268","DOI":"10.7554\/eLife.31268","article-title":"Metformin extends C. elegans lifespan through lysosomal pathway","volume":"6","author":"Chen","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.lfs.2020.118818_bb0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/jomt.jomt_2_18","article-title":"Study of the effect of pantoprazole on glycemic control of type-2 diabetes mellitus in tertiary care center and hospital in North India","volume":"20","author":"Agrawal","year":"2018","journal-title":"J. Med. Trop."},{"key":"10.1016\/j.lfs.2020.118818_bb0340","first-page":"117","article-title":"Long term evaluation of glycemic control in patients with type 2 diabetes receiving either alogliptin and lansoprazole or alogliptin mono-therapy for 3 months followed by alogliptin mono-therapy: a retrospective analysis","volume":"42","author":"Takebayashi","year":"2015","journal-title":"Dokkyo J. Med. Sci."},{"key":"10.1016\/j.lfs.2020.118818_bb0345","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1089\/met.2018.0138","article-title":"The effect of proton pump inhibitors on glycemic control in patients with type 2 diabetes","volume":"17","author":"Villegas","year":"2019","journal-title":"Metab. Syndr. Relat. Disord."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052031571X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052031571X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:39:10Z","timestamp":1758400750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002432052031571X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":69,"alternative-id":["S002432052031571X"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118818","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autophagy blockade mechanistically links proton pump inhibitors to worsened diabetic nephropathy and aborts the renoprotection of metformin\/enalapril","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118818","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"118818"}}